MSFT

Microsoft Corporation

76
Fundamentals75/ 100
Valuation69/ 100
Upside potential75/ 100
Risk potential10/ 100

MSFT has the edge over TRT overall, supported by stronger valuation and lower modeled downside.

TRT

Trio-Tech International

52
Fundamentals70/ 100
Valuation15/ 100
Upside potential63/ 100
Risk potential31/ 100

TRT trails on the overall score without a compensating advantage in the available component scores.

MSFT Fundamentals

MetricStatus
Healthy
Strong
Healthy
Strong

MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.

TRT Fundamentals

MetricStatus
Healthy
Healthy
Under pressure
Strong

TRT's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.

MSFT PE Valuation

CHEAPFAIREXPENSIVE11x21x32x42x
CHEAPFAIREXPENSIVE11x21x32x42x
LevelPEPriceVs current
Forward25x$523—
Cheap27x$525+0.4%
Current27x$523—
Fair34x$652+25%
Expensive37x$711+36%

Historical ranges are pointers, not guarantees.

MSFT has the edge over TRT in the historical PE scenario, which offers more potential upside but is not a forecast.

TRT PE Valuation

CHEAPFAIREXPENSIVE116x232x348x463x
CHEAPFAIREXPENSIVE116x232x348x463x
LevelPEPriceVs current
Cheap9.4x$0.56-90%
Fair24x$1.46-74%
Expensive47x$2.81-50%
Current93x$5.60—

Historical ranges are pointers, not guarantees.

TRT's PE is in its expensive range at 93x.

MSFT Forward outlook

MetricOutlook
Improving
Strong growth
Strong growth
Stable
Moderate
High

Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.

TRT Forward outlook

There aren't enough analyst estimates for TRT to show an outlook.

MSFT Risk to reward

ScenarioChangePrice
Upside+28%$671.86
Downside-10%$472.97

Calculated from the latest close: $523.00 on Nov 12.

MSFT has a better modeled risk to reward balance than TRT, with more potential upside relative to its potential downside.

TRT Risk to reward

ScenarioChangePrice
Upside+53%$8.58
Downside-31%$3.86

Calculated from the latest close: $5.60 on Nov 12.

TRT trails MSFT on modeled risk to reward, with less potential upside relative to its potential downside.

MSFT Earnings Per Share

Q4 2023: $11.05Q1 2024: $11.54Q2 2024: $11.80Q3 2024: $12.11Q4 2024: $12.41Q1 2025: $12.93Q2 2025: $13.64Q3 2025: $14.06Q4 2025: $15.99Q1 2026: $16.80Q2 2026: $17.95Q3 2026: $19.15Forward: $20.79
Q4 2023: $11.05Q1 2024: $11.54Q2 2024: $11.80Q3 2024: $12.11Q4 2024: $12.41Q1 2025: $12.93Q2 2025: $13.64Q3 2025: $14.06Q4 2025: $15.99Q1 2026: $16.80Q2 2026: $17.95Q3 2026: $19.15Forward: $20.79
QuarterTTM EPSYoY
Forward$20.79+8.6%
Q3 2026$19.15+36%
Q2 2026$17.95+32%
Q1 2026$16.80+30%
Q4 2025$15.99+29%
Q3 2025$14.06+16%
Q2 2025$13.64+16%
Q1 2025$12.93+12%
Q4 2024$12.41+12%

MSFT has the edge over TRT on earnings, with more consistent year-over-year improvement.

TRT Earnings Per Share

Q4 2023: $0.11Q1 2024: $0.12Q2 2024: $0.12Q3 2024: $0.06Q4 2024: $0.06Q1 2025: $-0.01Q2 2025: $-0.01Q3 2025: $0.03Q4 2025: $-0.01Q1 2026: $0.04Q2 2026: $0.00Q3 2026: $0.06
Q4 2023: $0.11Q1 2024: $0.12Q2 2024: $0.12Q3 2024: $0.06Q4 2024: $0.06Q1 2025: $-0.01Q2 2025: $-0.01Q3 2025: $0.03Q4 2025: $-0.01Q1 2026: $0.04Q2 2026: $0.00Q3 2026: $0.06
QuarterTTM EPSYoY
Q3 2026$0.06+100%
Q2 2026$0.00+$0.01
Q1 2026$0.04+$0.05
Q4 2025-$0.01-117%
Q3 2025$0.03-50%
Q2 2025-$0.01-108%
Q1 2025-$0.01-108%
Q4 2024$0.06-45%

TRT's earnings per share have fallen from their peak: $0.06 over the past year, against $0.28 in mid-2022.

MSFT Quarterly Revenue

Q4 2023: $62BQ1 2024: $61.9BQ2 2024: $64.7BQ3 2024: $65.6BQ4 2024: $69.6BQ1 2025: $70.1BQ2 2025: $76.4BQ3 2025: $77.7BQ4 2025: $81.3BQ1 2026: $82.9BQ2 2026: $90BQ3 2026: $92.3B
Q4 2023: $62BQ1 2024: $61.9BQ2 2024: $64.7BQ3 2024: $65.6BQ4 2024: $69.6BQ1 2025: $70.1BQ2 2025: $76.4BQ3 2025: $77.7BQ4 2025: $81.3BQ1 2026: $82.9BQ2 2026: $90BQ3 2026: $92.3B
QuarterRevenueYoY
Q3 2026$92.3B+19%
Q2 2026$90B+18%
Q1 2026$82.9B+18%
Q4 2025$81.3B+17%
Q3 2025$77.7B+18%
Q2 2025$76.4B+18%
Q1 2025$70.1B+13%
Q4 2024$69.6B+12%

MSFT's revenue has grown year over year every quarter since late 2020: $92.3B last quarter, up 19% from the same quarter a year ago.

TRT Quarterly Revenue

Q4 2023: $12MQ1 2024: $10MQ2 2024: $10MQ3 2024: $10MQ4 2024: $9MQ1 2025: $7MQ2 2025: $11MQ3 2025: $16MQ4 2025: $16MQ1 2026: $17MQ2 2026: $15MQ3 2026: $20M
Q4 2023: $12MQ1 2024: $10MQ2 2024: $10MQ3 2024: $10MQ4 2024: $9MQ1 2025: $7MQ2 2025: $11MQ3 2025: $16MQ4 2025: $16MQ1 2026: $17MQ2 2026: $15MQ3 2026: $20M
QuarterRevenueYoY
Q3 2026$19.9M+29%
Q2 2026$14.9M+40%
Q1 2026$16.5M+124%
Q4 2025$15.6M+82%
Q3 2025$15.5M+58%
Q2 2025$10.7M+9.5%
Q1 2025$7.4M-29%
Q4 2024$8.6M-29%

TRT's revenue has grown year over year for six quarters in a row: $20M last quarter, up 29% from the same quarter a year ago.

MSFT Free Cash Flow

Q4 2023: $9.1BQ1 2024: $21BQ2 2024: $23.3BQ3 2024: $19.3BQ4 2024: $6.5BQ1 2025: $20.3BQ2 2025: $25.6BQ3 2025: $25.7BQ4 2025: $5.9BQ1 2026: $15.8BQ2 2026: $19.6BQ3 2026: $18.6B
Q4 2023: $9.1BQ1 2024: $21BQ2 2024: $23.3BQ3 2024: $19.3BQ4 2024: $6.5BQ1 2025: $20.3BQ2 2025: $25.6BQ3 2025: $25.7BQ4 2025: $5.9BQ1 2026: $15.8BQ2 2026: $19.6BQ3 2026: $18.6B
QuarterFree cash flowYoY
Q3 2026$18.6B-27%
Q2 2026$19.6B-23%
Q1 2026$15.8B-22%
Q4 2025$5.9B-9.3%
Q3 2025$25.7B+33%
Q2 2025$25.6B+9.6%
Q1 2025$20.3B-3.2%
Q4 2024$6.5B-29%

MSFT has the edge over TRT on cash generation, producing positive trailing cash flow while its opponent burns cash.

TRT Free Cash Flow

Q4 2023: --Q1 2024: $1MQ2 2024: −$289,000Q3 2024: −$2MQ4 2024: $2MQ1 2025: $623,000Q2 2025: −$1MQ3 2025: $887,000Q4 2025: −$152,000Q1 2026: $707,000Q2 2026: $244,000Q3 2026: −$4M
Q4 2023: --Q1 2024: $1MQ2 2024: −$289,000Q3 2024: −$2MQ4 2024: $2MQ1 2025: $623,000Q2 2025: −$1MQ3 2025: $887,000Q4 2025: −$152,000Q1 2026: $707,000Q2 2026: $244,000Q3 2026: −$4M
QuarterFree cash flowYoY
Q3 2026-$4.1M-567%
Q2 2026$244K+$1.5M
Q1 2026$707K+13%
Q4 2025-$152K-108%
Q3 2025$887K+$2.8M
Q2 2025-$1.2M-$932K
Q1 2025$623K-48%
Q2 2024-$289K-123%

TRT's free cash flow was −$3M over the past year, against $2M the year before.

MSFT Total Shares

Q4 2023: 7.5BQ1 2024: 7.5BQ2 2024: 7.5BQ3 2024: 7.5BQ4 2024: 7.5BQ1 2025: 7.5BQ2 2025: 7.5BQ3 2025: 7.5BQ4 2025: 7.5BQ1 2026: 7.4BQ2 2026: 7.5BQ3 2026: 7.4B
Q4 2023: 7.5BQ1 2024: 7.5BQ2 2024: 7.5BQ3 2024: 7.5BQ4 2024: 7.5BQ1 2025: 7.5BQ2 2025: 7.5BQ3 2025: 7.5BQ4 2025: 7.5BQ1 2026: 7.4BQ2 2026: 7.5BQ3 2026: 7.4B
PeriodChange %Net change
Quarterly-0.1%-7M shares
1 year-0.3%-20M shares
3 years-0.2%-16M shares
5 years-1.6%-121M shares
Available history-3.2%-245M shares

MSFT has the edge over TRT on shareholder dilution, with a more favorable share count trend.

TRT Total Shares

Q4 2023: 9MQ1 2024: 9MQ2 2024: 9MQ3 2024: 9MQ4 2024: 9MQ1 2025: 9MQ2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 10MQ2 2026: 9MQ3 2026: 11M
Q4 2023: 9MQ1 2024: 9MQ2 2024: 9MQ3 2024: 9MQ4 2024: 9MQ1 2025: 9MQ2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 10MQ2 2026: 9MQ3 2026: 11M
PeriodChange %Net change
Quarterly+27%+2.4M shares
1 year+31%+2.7M shares
3 years+33%+2.8M shares
5 years+42%+3.4M shares

TRT has 11M diluted shares, up 31% from a year ago.

MSFT Net Leverage

Q2 2026: 0.1xQ3 2026: 0.1x
Q2 2026: 0.1xQ3 2026: 0.1x
QuarterNet LeverageStatus
Q3 20260.1xVery low
Q2 20260.1xVery low

MSFT's net debt is less than a year of its operating earnings (EBITDA).

TRT Net Leverage

Q4 2023: -1.5xQ1 2024: -1.7xQ2 2024: -1.7xQ3 2024: -1.7xQ4 2024: -2.8xQ1 2025: -3.5xQ2 2025: -3.4xQ3 2025: -4.3xQ4 2025: -4.6xQ1 2026: -4.5xQ2 2026: -10.1xQ3 2026: -4.9x
Q4 2023: -1.5xQ1 2024: -1.7xQ2 2024: -1.7xQ3 2024: -1.7xQ4 2024: -2.8xQ1 2025: -3.5xQ2 2025: -3.4xQ3 2025: -4.3xQ4 2025: -4.6xQ1 2026: -4.5xQ2 2026: -10.1xQ3 2026: -4.9x
QuarterNet LeverageStatus
Q3 2026-4.9xNet Cash
Q2 2026-10.1xNet Cash
Q1 2026-4.5xNet Cash
Q4 2025-4.6xNet Cash
Q3 2025-4.3xNet Cash
Q2 2025-3.4xNet Cash
Q1 2025-3.5xNet Cash
Q4 2024-2.8xNet Cash

TRT has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.

MSFT Weekly Momentum

MetricValueStatus
RSI62.1Neutral
Stochastic68.0Neutral

MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).

TRT Weekly Momentum

MetricValueStatus
RSI41.4Neutral
Stochastic7.5Oversold

TRT's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).

MSFT PE vs Technology Sector

MetricMSFTSector medianRelative
PE27x28x2% below
PE %163519 pts below

MSFT has the edge over TRT on valuation relative to its sector.

TRT PE vs Technology Sector

MetricTRTSector medianRelative
PE93x28x235% above
PE %883553 pts above

TRT is trading at 93x earnings, a 235% premium to the Technology sector's median of 28x.

MSFT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$524.70.3% below
20 week MA$484.87.9% above
50 week MA$446.917% above
100 week MA$453.815% above
200 week MA$411.527% above

MSFT has the edge over TRT on trend strength, trading above more of its moving averages.

TRT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$5.403.7% above
20 week MA$8.4334% below
50 week MA$8.4734% below
100 week MA$5.722.1% below
200 week MA$4.2931% above

TRT's trend is mixed: it's above two of its five weekly moving averages, and 31% above its 200-week average.

MSFT Yearly ROI

YearStart priceEnd priceROI
2020$159.0$222.8+40%
2021$222.8$334.7+50%
2022$334.7$238.7-29%
2023$238.7$376.0+58%
2024$376.0$430.5+14%
2025$430.5$487.7+13%
2026 YTD$487.7$523.0+7.2%

MSFT has the edge over TRT on returns for 2026, with the stronger performance.

TRT Yearly ROI

YearStart priceEnd priceROI
2020$2.11$1.96-7.1%
2021$1.96$6.27+220%
2022$6.27$2.29-63%
2023$2.29$2.54+11%
2024$2.54$2.96+17%
2025$2.96$7.00+136%
2026 YTD$7.00$5.60-20%

TRT's yearly returns have swung widely, from +220% in 2021 to −63% in 2022. It's down 20% so far in 2026.

Give your agent the market.

Get API key